565194-75-4

Usage

Uses

Used in Pharmaceutical Industry:
4-(TETRAHYDRO-FURAN-2-YLMETHOXY)-BENZOIC ACID is used as a building block for creating new molecules with potential therapeutic effects. Its unique structure and properties make it a valuable tool in drug development, contributing to the advancement of novel pharmaceuticals.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(TETRAHYDRO-FURAN-2-YLMETHOXY)-BENZOIC ACID is utilized as a key component in the synthesis of complex organic compounds, facilitating the development of innovative chemical entities.
Used in Antimicrobial Applications:
4-(TETRAHYDRO-FURAN-2-YLMETHOXY)-BENZOIC ACID is studied for its potential antimicrobial properties, suggesting its use in combating various microorganisms and contributing to the development of new antimicrobial agents.
Used in Antioxidant Applications:
4-(TETRAHYDRO-FURAN-2-YLMETHOXY)-BENZOIC ACID is also being investigated for its antioxidant properties, indicating its potential use in various applications where antioxidant capabilities are beneficial, such as in the food industry, cosmetics, or pharmaceuticals to protect against oxidative stress and related conditions.

Upstream product

• 97-99-4 Tetrahydrofurfuryl alcohol 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 1236403-74-9 N-[8-methyl-3-({[(2S)-tetrahydrofuran-2-ylmethyl]amino}methyl)quinolin-7-yl]-4-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide 
• 1236404-38-8 N-(3-{[(5-hydroxytricyclo[3.3.1.13,7]dec-2-yl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236404-40-2 N-[8-methyl-3-({[2-(l-methylethoxy)ethyl]amino}methyl)quinolin-7-yl]-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236404-43-5 N-(3-{[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]methyl)-8-methylquinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236404-96-8 N-(3-formyl-8-methylquinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-59-0 N-(3-{[(2-hydroxy-2-methylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-62-5 N-[3-({[(1S,2S)-2-hydroxycyclohexyl]amino}methyl)-8-methylquinolin-7-yl]-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-63-6 N-[3-({[(1S,2S)-2-hydroxycyclopentyl]amino}methyl)-8-methylquinolin-7-yl]-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-76-1 N-(3-{[(2,2-dimethylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-79-4 N-{3-[(cyclopropylamino)methyl]-8-methylquinolin-7-yl}-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-80-7 N-(8-methyl-3-{[(1-methylethyl)amino]methyl}quinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-82-9 N-{8-methyl-3-[(tetrahydro-2H-pyran-4-ylamino)methyl]quinolin-7-yl}-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 1236403-84-1 N-(3-{[(cyclopropylmethyl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-2-ylmethoxy)benzamide 
• 940511-56-8 C₁₉H₂₀N₂O₅ 

Relevant academic research and scientific papers

QUINOLINE DERIVATIVE

The present invention provides a compound having a melanin-concentrating hormone receptor antagonistic action and low toxicity, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.